+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Sciatic Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Sciatic Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Atherosclerosis Drugs Global Market Report 2024 - Product Thumbnail Image

Atherosclerosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Eylea Global Market Report 2024 - Product Thumbnail Image

Eylea Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Acute Ischemic Stroke Drugs Global Market Report 2024 - Product Thumbnail Image

Acute Ischemic Stroke Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Ischemic Stroke - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemic Stroke - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
Loading Indicator